Parkman Healthcare Partners LLC Biocryst Pharmaceuticals Inc Transaction History

Parkman Healthcare Partners LLC

$770 Million
Q1 2025

A detailed history of Parkman Healthcare Partners LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 1,000,562 shares of BCRX stock, worth $8.76 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

1,000,562

Previous 216,881 361.34%

Holding current value

$8.76 Million

Previous $1.63 Million 360.37%

% of portfolio

0.97%

Previous 0.24%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$7.06 - $9.39 $5.53 Million - $7.36 Million	783,681 Added 361.34%	1,000,562 $7.5 Million
Q4 2024 Feb 14, 2025	SELL	$7.03 - $8.43 $1.74 Million - $2.08 Million	-247,167 Reduced 53.26%	216,881 $1.63 Million
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $407,676 - $552,684	63,600 Added 15.88%	464,048 $3.53 Million
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $1.65 Million - $2.72 Million	400,448 New	400,448 $2.47 Million
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $3.76 Million - $8.53 Million	-476,978 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $889,854 - $1.52 Million	76,977 Added 19.24%	476,978 $7.76 Million
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $3.33 Million - $4.61 Million	298,040 Added 292.31%	400,001 $5.54 Million
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $3.55 Million - $4.41 Million	-250,000 Reduced 71.03%	101,961 $1.47 Million
Q2 2021 Aug 13, 2021	BUY	$9.5 - $17.24 $1.02 Million - $1.85 Million	107,281 Added 43.85%	351,961 $5.57 Million
Q1 2021 May 14, 2021	SELL	$7.37 - $13.61 $2.16 Million - $4 Million	-293,690 Reduced 54.55%	244,680 $2.49 Million
Q4 2020 Feb 12, 2021	SELL	$3.37 - $8.61 $884,186 - $2.26 Million	-262,370 Reduced 32.77%	538,370 $4.01 Million
Q3 2020 Nov 13, 2020	SELL	$3.43 - $5.53 $342,547 - $552,270	-99,868 Reduced 11.09%	800,740 $2.75 Million
Q2 2020 Aug 13, 2020	SELL	$1.9 - $5.61 $180,500 - $532,950	-95,000 Reduced 9.54%	900,608 $4.29 Million
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $232,966 - $598,432	-145,604 Reduced 12.76%	995,608 $1.99 Million
Q4 2019 Feb 13, 2020	BUY	$1.59 - $3.45 $1.81 Million - $3.94 Million	1,141,212 New	1,141,212 $3.94 Million

Others Institutions Holding BCRX

# of Institutions

294

Shares Held

177M

Call Options Held

721K

Put Options Held

489K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.63B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Biocryst Pharmaceuticals Inc Transaction History